sec filing
AB
NASDAQ · ABOS
Acumen Pharmaceuticals, Inc.
Healthcare · Biotechnology
$2.27
Down-$0.04 (-1.80%)
Updated Oct 27, 2026, 3:38 PM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 190.2M
- P/E ratio
- -1.43
- Dividend yield
- 0.00%
- 52-week range
- $1.50 – $3.60
- Volume
- 1.65M
- Avg. volume
- 585.74K
Price performance · ABOS
ABOS price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 26, 2026
ABOS closed at $2.27 after 21 trading sessions, down 1.30% for the selected period.
- Last close
- $2.27
- Period change
- -1.30%
- Period low
- $1.67
- Period high
- $2.30
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | $2.13 | $2.42 | $1.97 | $2.27 | 1.65M |
| Oct 23, 2026 | $2.05 | $2.05 | $1.895 | $1.98 | 541.79K |
| Oct 22, 2026 | $2.03 | $2.14 | $2.01 | $2.06 | 569.49K |
| Oct 21, 2026 | $2.00 | $2.08 | $1.99 | $2.03 | 397.71K |
| Oct 20, 2026 | $1.78 | $2.0699 | $1.764 | $2.015 | 784.62K |
| Oct 19, 2026 | $1.70 | $1.78 | $1.67 | $1.77 | 274.68K |
| Oct 16, 2026 | $1.67 | $1.715 | $1.62 | $1.69 | 449.34K |
| Oct 15, 2026 | $1.71 | $1.755 | $1.66 | $1.67 | 602.71K |
| Oct 14, 2026 | $1.81 | $1.87 | $1.71 | $1.745 | 620.86K |
| Oct 13, 2026 | $2.00 | $2.00 | $1.81 | $1.815 | 646.34K |
| Oct 12, 2026 | $2.14 | $2.14 | $2.00 | $2.02 | 291.65K |
| Oct 9, 2026 | $2.12 | $2.17 | $2.081 | $2.14 | 357.54K |
| Oct 8, 2026 | $2.09 | $2.135 | $2.0201 | $2.10 | 505.17K |
| Oct 7, 2026 | $2.02 | $2.17 | $2.00 | $2.10 | 623.09K |
| Oct 6, 2026 | $2.13 | $2.14 | $2.00 | $2.03 | 562.87K |
| Oct 5, 2026 | $2.04 | $2.16 | $2.015 | $2.13 | 713.98K |
| Oct 2, 2026 | $2.10 | $2.10 | $2.015 | $2.04 | 580.52K |
| Oct 1, 2026 | $2.22 | $2.29 | $2.07 | $2.07 | 833.41K |
| Sep 30, 2026 | $2.25 | $2.45 | $2.10 | $2.22 | 1.48M |
| Sep 29, 2026 | $2.30 | $2.42 | $2.22 | $2.245 | 1.09M |
| Sep 28, 2026 | $2.22 | $2.375 | $2.19 | $2.30 | 856.38K |
Latest ABOS news
The latest Smart Investors Daily articles mentioning ABOS.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…